Somnath Mahapatra

6PUBLICATIONS
58CO-AUTHORS
Predictive and prognostic markersMolecular targetsInnate immunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 29, 2026
Invasive urothelial carcinoma in association with surface low-grade papillary urothelial carcinoma: clinical and pathologic insights from a rare entity.

|Oct 03, 2025
Targeting histone H2B acetylated enhanceosomes via p300/CBP degradation in prostate cancer.

Jie Luo, Zhixiang Chen, Yuanyuan Qiao

|Jun 26, 2025
Divergent FOXA1 mutations drive prostate tumorigenesis and therapy-resistant cellular plasticity.

Sanjana Eyunni, Rahul Mannan, Yuping Zhang

|Nov 14, 2024
The UBA1-STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade.

Yi Bao, Gabriel Cruz, Yuping Zhang

|Sep 09, 2024
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis.

Abhijit Parolia, Sanjana Eyunni, Brijesh Kumar Verma

|May 31, 2024
Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation.

Raymond J Kostlan, John T Phoenix, Audris Budreika

Pageof 1

Frequent Collaborators

5 joint publications

Arul M Chinnaiyan

5 joint publications

Rahul Mannan

4 joint publications

Yuanyuan Qiao

3 joint publications

James M George